Partnership Overview
Hippocratic AI, a company specializing in generative AI for healthcare, has formed a strategic alliance with Burjeel Holdings, a prominent healthcare services provider based in the United Arab Emirates. This partnership aims to improve healthcare delivery across the Middle East and North Africa (MENA) region.
Key Details of the Partnership
- The announcement was made during the Abu Dhabi Global Healthcare Week.
- Hippocratic AI will develop generative AI healthcare agents for patient-facing non-diagnostic clinical tasks.
- These AI agents will be implemented in Burjeel Holdings’ healthcare facilities and physiotherapy clinics in the UAE and Oman.
Enhancing Patient Engagement
The integration of Hippocratic AI’s technology is expected to:
- Transform patient engagement.
- Facilitate personalized and empathetic clinical conversations.
Multilingual Capabilities
The partnership will also feature:
- Multilingual AI agents capable of communicating in Arabic, including the Emirati dialect.
- Support for over 15 languages, such as Spanish, Mandarin, and Vietnamese.
- Plans to expand language support to cover nearly all major global languages.
Cultural Relevance
The collaboration aims to create:
- Personalized regional generative AI agents that align with local cultures and needs.
- AI agents across various specialties, including oncology, cardiology, neurology, and orthopedics.
Statements from Leadership
Munjal Shah, co-founder and CEO of Hippocratic AI, expressed pride in partnering with Burjeel Holdings, stating:
“This partnership supports our shared mission of achieving healthcare abundance. Our empathic genAI agents are designed to create a more compassionate and effective patient experience.”
Recent Developments
In addition to this partnership, Burjeel Holdings recently announced a collaboration with diagnostics company Genalyte to deploy the Merlin automated diagnostic system, pending FDA approval.
Hippocratic AI has also made significant strides, including:
- Appointing seven new executives following a $141 million Series B funding round.
- Receiving its first patent for innovations in safety-focused large language models.
This partnership marks a significant step in enhancing healthcare delivery in the MENA region through advanced AI technology.